Product Details
Product Name: Everolimus | CAS No.: 159351-69-6 |
EC-No.: 621-003-9 | Min. Order: 1g |
Purity: 99 | Supply Ability: 10kg |
Release date: 2025/07/29 |
CAS: 159351-69-6
MF: C53H83NO14
MW: 958.22
EINECS: 621-003-9
Melting point NA
Boiling point 998.7±75.0 °C(Predicted)
density 1.18±0.1 g/cm3(Predicted)
Fp 2℃
storage temp. −20°C
Everolimus (IX) (SDZ-RAD), was developed by Novartis as an immunosuppressant to be used in conjunction with cyclosporin in transplantation allograft rejection and was recently approved in the US in 2003. Another natural product that had been approved for use in transplantation is rapamycin (sirolimus) as an inejectable agent. In an attempt to develop an orally bioavailable immunosuppressant agent, many companies attempted modification of rapamycin itself.
Company Profile Introduction
You may like
-
CAS:314771-88-5
$1365.00 / 1KG
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$37.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-10-17 | |
$0.00/1kg |
VIP1Y
|
Jinan Ruitong Biotech Co., Ltd.
|
2025-09-03 | |
$0.00/1g |
VIP1Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2025-07-11 | |
$5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-29 | |
$/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
$0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-12-12 | |
$0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-09-07 | ||
$100.00/1kg |
Henan Bao Enluo International TradeCo.,LTD
|
2023-08-04 | ||
$0.00/1KG |
Hubei Harvest Chemical CO.,Ltd
|
2022-12-22 | ||
$0.00/25KG |
VIP6Y
|
Sichuan Zhuoyu Yantang Technology Co., Ltd.
|
2022-07-13 |
- Since: 2018-09-06
- Address: B801, Jintai District, Baoji City, Shaanxi Province, China, Dongling Financial Plaza, Jintai Distric
+86-13892490616
gksales1@gk-bio.com